Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Weissmann

Showing results (251-260 of 301) with videos related to

Pageof 31
Sort By:
The European Respiratory Journal|September 3, 2021
Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in miceMarija Gredic, Cheng-Yu Wu, Stefan Hadzic, et al.
Nature Communications|May 19, 2019
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertensionAstrid Weiss, Moritz Christian Neubauer, Dinesh Yerabolu, et al.
American Journal of Respiratory Cell and Molecular Biology|June 29, 2017
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular HypertrophyBaktybek Kojonazarov, Tatyana Novoyatleva, Mario Boehm, et al.
Nature Genetics|December 20, 2022
Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosineFan Wu, Xiang Li, Mario Looso, et al.
American Journal of Respiratory Cell and Molecular Biology|May 7, 2013
Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxiaAdel Bakr, Oleg Pak, Ashraf Taye, et al.
Circulation|August 30, 2008
Fhl-1, a new key protein in pulmonary hypertensionGrazyna Kwapiszewska, Malgorzata Wygrecka, Leigh M Marsh, et al.
Circulation|April 18, 2007
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapyRalph Theo Schermuly, Soni Savai Pullamsetti, Grazyna Kwapiszewska, et al.
American Journal of Respiratory Cell and Molecular Biology|April 18, 2013
Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease modelOleg Pak, Natascha Sommer, Timm Hoeres, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2010
Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertensionMatthias Hecker, Zbigniew Zaslona, Grazyna Kwapiszewska, et al.
International Journal of Cardiology|October 14, 2018
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018Andrea Olschewski, Eva M Berghausen, Christina A Eichstaedt, et al.
Pageof 31

Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
The European Respiratory Journal|September 3, 2021
Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in miceMarija Gredic, Cheng-Yu Wu, Stefan Hadzic, et al.
Nature Communications|May 19, 2019
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertensionAstrid Weiss, Moritz Christian Neubauer, Dinesh Yerabolu, et al.
American Journal of Respiratory Cell and Molecular Biology|June 29, 2017
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular HypertrophyBaktybek Kojonazarov, Tatyana Novoyatleva, Mario Boehm, et al.
Nature Genetics|December 20, 2022
Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosineFan Wu, Xiang Li, Mario Looso, et al.
American Journal of Respiratory Cell and Molecular Biology|May 7, 2013
Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxiaAdel Bakr, Oleg Pak, Ashraf Taye, et al.
Circulation|August 30, 2008
Fhl-1, a new key protein in pulmonary hypertensionGrazyna Kwapiszewska, Malgorzata Wygrecka, Leigh M Marsh, et al.
Circulation|April 18, 2007
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapyRalph Theo Schermuly, Soni Savai Pullamsetti, Grazyna Kwapiszewska, et al.
American Journal of Respiratory Cell and Molecular Biology|April 18, 2013
Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease modelOleg Pak, Natascha Sommer, Timm Hoeres, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2010
Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertensionMatthias Hecker, Zbigniew Zaslona, Grazyna Kwapiszewska, et al.
International Journal of Cardiology|October 14, 2018
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018Andrea Olschewski, Eva M Berghausen, Christina A Eichstaedt, et al.
Pageof 31